Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2021 08:00 ET | Source: NuCana plc

NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer

EDINBURGH, United Kingdom, Sept. 29, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Acelarin...
September 16, 2021 08:00 ET | Source: NuCana plc

NuCana Announces Four Poster Presentations at the ESMO Congress 2021

NUC-3373 Continues to Demonstrate Encouraging Efficacy Signals and a Favorable Safety Profile in Patients with Advanced Colorectal Cancer NUC-3373 Phase 1 Study Demonstrated Encouraging...
September 15, 2021 08:00 ET | Source: NuCana plc

NuCana Announces Enrollment of Required Number of Patients to Conduct First Interim Analysis in the Phase III Biliary Tract Cancer Study

Enrollment of 418 Evaluable Patients Expected to Enable First Interim Analysis in the First Half of 2022 Data from First Interim Analysis May Support an NDA Submission in the United States under the...
September 01, 2021 08:00 ET | Source: NuCana plc

NuCana to Participate in Three Upcoming Investor Conferences

EDINBURGH, United Kingdom, Sept. 01, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...
August 19, 2021 16:01 ET | Source: NuCana plc

NuCana Reports Second Quarter 2021 Financial Results and Provides Business Update

EDINBURGH, United Kingdom, Aug. 19, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced financial results for the second quarter ended June 30, 2021 and provided an update on its broad...
August 10, 2021 08:00 ET | Source: NuCana plc

NuCana Appoints Jeffrey D. Bloss, M.D. as Chief Medical Officer

EDINBURGH, United Kingdom, Aug. 10, 2021 (GLOBE NEWSWIRE) -- NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer,...
May 25, 2021 08:00 ET | Source: NuCana plc

NuCana to Present at the Jefferies Virtual Healthcare Conference

EDINBURGH, United Kingdom, May 25, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...
May 19, 2021 16:01 ET | Source: NuCana plc

NuCana Reports First Quarter 2021 Financial Results and Provides Business Update

Presented Encouraging Clinical Data at ASCO-GI and AACR Additional Clinical Data Announcements and Study Initiations Expected in 2021 EDINBURGH, United Kingdom, May 19, 2021 (GLOBE NEWSWIRE) --...
April 28, 2021 08:00 ET | Source: NuCana plc

NuCana to Participate in the 7th Annual Truist Securities Life Sciences Summit

EDINBURGH, United Kingdom, April 28, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will host...
April 10, 2021 08:30 ET | Source: NuCana plc

NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021

NUC-3373 Shows Encouraging Efficacy Signals and a Favorable Safety Profile in Patients with Advanced Colorectal Cancer NUC-3373 Promotes Natural Killer Cell Activation by Colorectal Cancer...